Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

bioAffinity Technologies (BIAF) Depreciation & Amortization - Total (2022 - 2025)

bioAffinity Technologies (BIAF) has disclosed Depreciation & Amortization - Total for 4 consecutive years, with $44599.0 as the latest value for Q3 2025.

  • On a quarterly basis, Depreciation & Amortization - Total rose 10.2% to $44599.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $175636.0, a 38.55% decrease, with the full-year FY2024 number at $162332.0, down 30.35% from a year prior.
  • Depreciation & Amortization - Total was $44599.0 for Q3 2025 at bioAffinity Technologies, roughly flat from $44468.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization - Total ranged from a high of $166284.0 in Q4 2023 to a low of $800.0 in Q3 2022.
  • A 4-year average of $44035.9 and a median of $40357.5 in 2024 define the central range for Depreciation & Amortization - Total.
  • Peak YoY movement for Depreciation & Amortization - Total: soared 2837.5% in 2023, then crashed 74.26% in 2024.
  • bioAffinity Technologies' Depreciation & Amortization - Total stood at $800.0 in 2022, then surged by 20685.5% to $166284.0 in 2023, then plummeted by 74.26% to $42806.0 in 2024, then grew by 4.19% to $44599.0 in 2025.
  • Per Business Quant, the three most recent readings for BIAF's Depreciation & Amortization - Total are $44599.0 (Q3 2025), $44468.0 (Q2 2025), and $43763.0 (Q1 2025).